Verastem, Inc. Gain (Loss) on Disposition of Assets
Verastem, Inc. (VSTM) reported Gain (Loss) on Disposition of Assets of $79.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-18.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2021-03-18
- Verastem, Inc. gain (loss) on disposition of assets for the quarter ending 2018-12-31 was $0.00.
- Verastem, Inc. gain (loss) on disposition of assets for the quarter ending 2018-09-30 was $0.00.
- Verastem, Inc. gain (loss) on disposition of assets for the quarter ending 2018-06-30 was $46.00K.
- Verastem, Inc. gain (loss) on disposition of assets for the quarter ending 2018-03-31 was $33.00K.
- Verastem, Inc. gain (loss) on disposition of assets for fiscal 2018 was $79.00K.
- Verastem, Inc. gain (loss) on disposition of assets for fiscal 2015 was -$46.00K.
- Verastem, Inc. gain (loss) on disposition of assets for fiscal 2014 was -$4.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $0.00 derived: sum of 2 quarters · filed 2021-03-18 | $46.00K derived: sum of 3 quarters · filed 2021-03-18 | $79.00K 10-K · filed 2021-03-18 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $46.00K derived: sum of 2 quarters · filed 2019-10-30 | $79.00K 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $79.00K 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $33.00K 10-Q · filed 2019-05-09 | |||
| 2015-12-31 | -$46.00K 10-K · filed 2018-03-13 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | -$4.00K 10-K · filed 2017-03-23 | ||
| 2014-09-30 | -$4.00K 10-Q · filed 2015-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |